Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O’Shea, Daniella M. Schwartz, Alejandro V. Villarino, et al.
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 311-328
Open Access | Times Cited: 1322

Showing 26-50 of 1322 citing articles:

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Robert Roskoski
Pharmacological Research (2016) Vol. 111, pp. 784-803
Closed Access | Times Cited: 306
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Robert Roskoski
Pharmacological Research (2021) Vol. 165, pp. 105463-105463
Closed Access | Times Cited: 303
Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
Andrea Majoros, Ekaterini Platanitis, Elisabeth Kernbauer-Hölzl, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 292
Selected cytokine pathways in rheumatoid arthritis
Mélissa Noack, Pierre Miossec
Seminars in Immunopathology (2017) Vol. 39, Iss. 4, pp. 365-383
Closed Access | Times Cited: 289
Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
Peter Van Dyken, Baptiste Lacoste
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 280
Familial chilblain lupus due to a gain-of-function mutation in STING
N. König, Christoph Fiehn, Christine Wolf, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 2, pp. 468-472
Open Access | Times Cited: 270
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner, Viktoria von Manstein
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 1-14
Closed Access | Times Cited: 270
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 253
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Farzan Solimani, Katharina Meier, Kamran Ghoreschi
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 242
Epigenetic control of innate and adaptive immune memory
Colleen M. Lau, Nicholas M. Adams, Clair D. Geary, et al.
Nature Immunology (2018) Vol. 19, Iss. 9, pp. 963-972
Open Access | Times Cited: 241
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Elizabeth R. Mann, Madhvi Menon, Sean Knight, et al.
Science Immunology (2020) Vol. 5, Iss. 51
Open Access | Times Cited: 241
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases
Zhaoqi Yan, Sara A. Gibson, Jessica A. Buckley, et al.
Clinical Immunology (2016) Vol. 189, pp. 4-13
Open Access | Times Cited: 240
Mechanisms of lncRNA/microRNA interactions in angiogenesis
Zhuo Zhao, Wei Sun, Ziyuan Guo, et al.
Life Sciences (2019) Vol. 254, pp. 116900-116900
Closed Access | Times Cited: 239
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
Tobias Merkle, Sarah K. Merz, Philipp Reautschnig, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 2, pp. 133-138
Closed Access | Times Cited: 237
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj, Moses M. Kasembeli, Prema Robinson, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 2, pp. 486-526
Open Access | Times Cited: 237
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration
Hongwei Qin, Jessica A. Buckley, Xinru Li, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 18, pp. 5144-5159
Open Access | Times Cited: 236
JAK inhibitors for the treatment of autoimmune and inflammatory diseases
Yvan Jamilloux, Thomas El Jammal, Lucine Vuitton, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 11, pp. 102390-102390
Closed Access | Times Cited: 231
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 1, pp. 71-87
Open Access | Times Cited: 231
JAK inhibitors in the treatment of atopic dermatitis
Raj Chovatiya, Amy S. Paller
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 927-940
Open Access | Times Cited: 231
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Thomas Worzfeld, Elke Pogge von Strandmann, Magdalena Huber, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 222
New Treatment Addressing the Pathogenesis of Psoriasis
Michio Tokuyama, Tomotaka Mabuchi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7488-7488
Open Access | Times Cited: 216
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
Paqui G. Través, Bernard P. Murray, Federico Campigotto, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 7, pp. 865-875
Open Access | Times Cited: 214
Immune-mediated inflammatory disease therapeutics: past, present and future
Iain B. McInnes, Ellen M. Gravallese
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 680-686
Open Access | Times Cited: 204
The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun, Yang Liu, Xiaoli Ma, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6923-6923
Open Access | Times Cited: 200
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Blood (2018) Vol. 131, Iss. 22, pp. 2454-2465
Open Access | Times Cited: 199

Scroll to top